http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9200384-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a99494c50d8e3062d596d8db9f299f8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6848
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6848
filingDate 1991-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46814bec65eabd65280683a3fa8dbe80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7eca843603bafe85ba1434527b2b48b
publicationDate 1992-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9200384-A1
titleOfInvention Improved in vitro enzymatic amplification method
abstract An improvement to the method of $i(in vitro) enzimatic amplification (PCR method) of a target DNA sequence present in heterologous DNA in a medium which comprises a DNA polymerase and a primer oligonucleotide. The method includes various cyclically repeated amplification steps whereby, at a chosen time following the end of the amplification cycles, the resulting amplification products are made unsuitable for later reamplification and/or, before the start of the PCR reaction, a pretreatment is carried out to selectively prevent any reamplification of the previous amplification products resulting from a PCR reaction using the same primer oligonucleotides.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0496483-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6252059-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9704126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0709468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0585660-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5856088-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0496483-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7083922-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6589734-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0617132-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5650302-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5712385-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0617132-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5824517-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0585660-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6649749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6495320-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0744470-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5605796-A
priorityDate 1990-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0407291-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0201184-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8909284-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0415755-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9012115-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9006376-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8911548-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0401037-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9001563-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414989

Total number of triples: 47.